Psyence Biomedical Ltd.
corporate_fare Company Profile
Psyence Biomedical Ltd. (NASDAQ:PBM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for PBM at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Psyence Biomedical Finalizes 1-for-6.25 Reverse Stock Split Effective February 2nd After Delay
- Psyence Biomedical Adjourns Shareholder Meeting Due to Lack of Quorum
- Psyence Biomedical Announces Second Reverse Stock Split to Maintain Nasdaq Listing
- Activist Investor KAOS Capital Reiterates Concerns, Seeks Board Changes at Psyence Biomedical
- Psyence Biomedical to Vote on Proposed Share Consolidation at Upcoming Meeting
Financial Snapshot
Insider Transactions
PBM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.